Literature DB >> 19130260

Iron acquisition by Pseudomonas aeruginosa in the lungs of patients with cystic fibrosis.

Iain L Lamont1, Anna F Konings, David W Reid.   

Abstract

The bacterium Pseudomonas aeruginosa is commonly isolated from the general environment and also infects the lungs of patients with cystic fibrosis (CF). Iron in mammals is not freely available to infecting pathogens although significant amounts of extracellular iron are available in the sputum that occurs in the lungs of CF patients. P. aeruginosa has a large number of systems to acquire this essential nutrient and many of these systems have been characterised in the laboratory. However, which iron acquisition systems are active in CF is not well understood. Here we review recent research that sheds light on how P. aeruginosa obtains iron in the lungs of CF patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19130260     DOI: 10.1007/s10534-008-9197-9

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  22 in total

1.  Virulence factors as predictive tools for drug resistance in Pseudomonas aeruginosa.

Authors:  Sónia Gonçalves Pereira; Ana Cristina Rosa; Olga Cardoso
Journal:  Virulence       Date:  2015-05-07       Impact factor: 5.882

2.  Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis.

Authors:  Alex H Gifford; Diana M Alexandru; Zhigang Li; Dana B Dorman; Lisa A Moulton; Katherine E Price; Thomas H Hampton; Mitchell L Sogin; Jonathan B Zuckerman; H Worth Parker; Bruce A Stanton; George A O'Toole
Journal:  J Cyst Fibros       Date:  2013-12-13       Impact factor: 5.482

3.  Iron homeostasis during cystic fibrosis pulmonary exacerbation.

Authors:  Alex H Gifford; Lisa A Moulton; Dana B Dorman; Gordana Olbina; Mark Westerman; H Worth Parker; Bruce A Stanton; George A O'Toole
Journal:  Clin Transl Sci       Date:  2012-06-01       Impact factor: 4.689

4.  The capability of Pseudomonas aeruginosa to recruit zinc under conditions of limited metal availability is affected by inactivation of the ZnuABC transporter.

Authors:  Melania D'Orazio; Maria Chiara Mastropasqua; Mauro Cerasi; Francesca Pacello; Ada Consalvo; Barbara Chirullo; Brittany Mortensen; Eric P Skaar; Domenico Ciavardelli; Paolo Pasquali; Andrea Battistoni
Journal:  Metallomics       Date:  2015-06       Impact factor: 4.526

5.  The Yfe and Feo transporters are involved in microaerobic growth and virulence of Yersinia pestis in bubonic plague.

Authors:  Jacqueline D Fetherston; Ildefonso Mier; Helena Truszczynska; Robert D Perry
Journal:  Infect Immun       Date:  2012-08-27       Impact factor: 3.441

Review 6.  Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.

Authors:  Jean Tyrrell; Máire Callaghan
Journal:  Microbiology (Reading)       Date:  2015-12-04       Impact factor: 2.777

7.  Pyoverdine, the Major Siderophore in Pseudomonas aeruginosa, Evades NGAL Recognition.

Authors:  Mary E Peek; Abhinav Bhatnagar; Nael A McCarty; Susu M Zughaier
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-09-02

Review 8.  Iron Acquisition Systems of Gram-negative Bacterial Pathogens Define TonB-Dependent Pathways to Novel Antibiotics.

Authors:  Phillip E Klebba; Salete M C Newton; David A Six; Ashish Kumar; Taihao Yang; Brittany L Nairn; Colton Munger; Somnath Chakravorty
Journal:  Chem Rev       Date:  2021-03-16       Impact factor: 60.622

9.  Culture-free diagnostics of Pseudomonas aeruginosa infection by silver nanorod array based SERS from clinical sputum samples.

Authors:  Xiaomeng Wu; Jing Chen; Xibo Li; Yiping Zhao; Susu M Zughaier
Journal:  Nanomedicine       Date:  2014-05-14       Impact factor: 5.307

Review 10.  Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.

Authors:  Matthew N Hurley; Miguel Cámara; Alan R Smyth
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.